| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2002 | CA2220602C Novel derivatives having a silicon chain on their ester moiety, photoprotective cosmetic compositions containing them and uses |
| 04/23/2002 | CA2220536C Novel derivatives having a silicon chain on their aromatic moiety, photoprotective cosmetic compositions containing them and uses |
| 04/23/2002 | CA2193149C Cationic therapuetic agents and delivery systems |
| 04/23/2002 | CA2191714C Therapeutic food composition and method to diminish blood sugar fluctuations |
| 04/23/2002 | CA2099771C Liposomal-polyene preliposomal powder and method for its preparation |
| 04/23/2002 | CA2073181C Optically pure r(-) albuterol for treating asthma |
| 04/23/2002 | CA2072148C Tissue moisturizing composition and method |
| 04/23/2002 | CA2069296C Combination preparation with antithrombotic action |
| 04/23/2002 | CA2067395C Antimetastatically acting agents |
| 04/23/2002 | CA2047389C Substituted piperidines and their use as inhibitors of cholesterol synthesis |
| 04/23/2002 | CA2042934C Treatment of ocular hypertension with an ocular synergistic combination |
| 04/23/2002 | CA2032261C Antiviral polyheterocyclic dimers |
| 04/23/2002 | CA2004127C Novel aminobenzoates |
| 04/20/2002 | CA2359383A1 Use of pdev inhibitors for improved fecundity in mammals |
| 04/18/2002 | WO2002031514A2 A method of determining the initial dose of vitamin d compounds |
| 04/18/2002 | WO2002031511A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
| 04/18/2002 | WO2002031499A1 Detection of neurodegenerative disorders |
| 04/18/2002 | WO2002031201A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 04/18/2002 | WO2002031197A1 Method for identifying increased risk of death from community acquired pneumonia |
| 04/18/2002 | WO2002031181A2 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
| 04/18/2002 | WO2002031128A1 Methods of agonizing and antagonizing fabk |
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002030990A1 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 04/18/2002 | WO2002030957A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells |
| 04/18/2002 | WO2002030943A1 Erythromycin derivative having novel crystal structures and processes for their production |
| 04/18/2002 | WO2002030942A2 Anhydro sugar derivatives of indolocarbazoles |
| 04/18/2002 | WO2002030941A2 Topoisomerase inhibitors |
| 04/18/2002 | WO2002030938A1 Benzhydryl derivatives |
| 04/18/2002 | WO2002030937A2 Labeled resiniferatoxin derivatives for use in vanilloid receptor binding assay |
| 04/18/2002 | WO2002030936A1 Pyrrole-condensed morphinoid derivatives |
| 04/18/2002 | WO2002030935A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/18/2002 | WO2002030933A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
| 04/18/2002 | WO2002030931A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030930A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
| 04/18/2002 | WO2002030927A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 04/18/2002 | WO2002030926A1 Quinazoline derivatives |
| 04/18/2002 | WO2002030924A1 Quinazoline derivatives with anti-tumour activity |
| 04/18/2002 | WO2002030923A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 04/18/2002 | WO2002030922A2 Dioxolane analogs for improved inter-cellular delivery |
| 04/18/2002 | WO2002030912A1 Benzodiazepine derivatives as inhibitors of gamma secretase |
| 04/18/2002 | WO2002030911A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 04/18/2002 | WO2002030910A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 04/18/2002 | WO2002030909A1 N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans |
| 04/18/2002 | WO2002030908A1 Inhibitors of protein kinases |
| 04/18/2002 | WO2002030907A1 Pyrazole derivatives for the treatment of viral diseases |
| 04/18/2002 | WO2002030906A1 Anti-tumour compounds |
| 04/18/2002 | WO2002030905A1 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide |
| 04/18/2002 | WO2002030904A1 Pyridinone derivatives for treatment of atherosclerosis |
| 04/18/2002 | WO2002030903A1 Process for producign optically active ethyl (3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate |
| 04/18/2002 | WO2002030902A1 Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride |
| 04/18/2002 | WO2002030900A1 Non-deliquescent salt of 4-hydroxypiperidine derivative |
| 04/18/2002 | WO2002030898A1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 04/18/2002 | WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS |
| 04/18/2002 | WO2002030894A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins |
| 04/18/2002 | WO2002030889A2 A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002030884A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030882A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030881A1 Sulfonylguanidine |
| 04/18/2002 | WO2002030879A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 04/18/2002 | WO2002030875A1 Beta-amino acid derivatives as integrin receptor antagonists |
| 04/18/2002 | WO2002030873A1 Mmp inhibitor |
| 04/18/2002 | WO2002030870A2 Substituted c-cyclohexylmethylamine derivatives |
| 04/18/2002 | WO2002030868A1 Selective maxi-k- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
| 04/18/2002 | WO2002030867A2 Drugs for diabetes |
| 04/18/2002 | WO2002030866A1 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 04/18/2002 | WO2002030863A2 Ether compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030860A2 Ketone compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030485A1 Embolic materials |
| 04/18/2002 | WO2002030473A1 Targeted therapeutic agents |
| 04/18/2002 | WO2002030469A2 Beta-lactam antibiotic-polysaccharide complex |
| 04/18/2002 | WO2002030465A2 Compositions that inhibit proliferation of cancer cells |
| 04/18/2002 | WO2002030462A2 Hedgehog antagonists, methods and uses related thereto |
| 04/18/2002 | WO2002030461A2 Methods for treating disorders of the female reproductive system |
| 04/18/2002 | WO2002030455A2 Agents for the treatment of viral infections |
| 04/18/2002 | WO2002030453A1 Methods of inhibiting angiogenesis using nadph oxidase inhibitors |
| 04/18/2002 | WO2002030448A2 Treatment of demyelinating diseases by administering gpe |
| 04/18/2002 | WO2002030447A2 Treatment of demyelinating diseases by administering gpe |
| 04/18/2002 | WO2002030441A2 Treatment of cancers by aplidine in conjunction with a myoprotector |
| 04/18/2002 | WO2002030439A1 A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity |
| 04/18/2002 | WO2002030438A1 Anticancer composition comprising sesquiterpenes isolated from resina ferulae |
| 04/18/2002 | WO2002030437A1 Citrus composition for hygiene, care or protection of teats |
| 04/18/2002 | WO2002030435A1 Treatment of t cell disorders |
| 04/18/2002 | WO2002030431A1 Obesity regulatory compositions |
| 04/18/2002 | WO2002030430A1 Use of vitamin d2 compounds for alopecia |
| 04/18/2002 | WO2002030429A1 Combination therapy for the treatment of estrogen-sensitive disease |
| 04/18/2002 | WO2002030428A1 Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 04/18/2002 | WO2002030427A1 Oral dosage forms for administration of the combination of tegafur, uracil, folinic acid, and vinorelbine and method of using the same |
| 04/18/2002 | WO2002030426A1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030424A1 Modified prodrug forms of ap/amp |
| 04/18/2002 | WO2002030423A1 NF-λB INHIBITORS |
| 04/18/2002 | WO2002030422A1 Use of defined substances that bind to the sigma receptor for combating sarcoma and carcinoma |
| 04/18/2002 | WO2002030421A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/18/2002 | WO2002030420A1 Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof |
| 04/18/2002 | WO2002030418A1 Compositions for improving lipid metabolism |
| 04/18/2002 | WO2002030417A1 Medicinal suspensions containing branched amino acids |
| 04/18/2002 | WO2002030416A1 Medicinal suspensions containing branched amino acids |
| 04/18/2002 | WO2002030415A1 Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
| 04/18/2002 | WO2002030414A1 Compositions comprising modafinil compounds |